CNMD
Income statement / Annual
Last year (2023), CONMED Corporation's total revenue was $1.24 B,
an increase of 19.06% from the previous year.
In 2023, CONMED Corporation's net income was $64.46 M.
See CONMED Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$1.24 B
|
$1.05 B
|
$1.01 B
|
$862.46 M
|
$955.10 M
|
$859.63 M
|
$796.39 M
|
$763.52 M
|
$719.17 M
|
$734.47 M
|
| Cost of Revenue |
$568.50 M |
$474.23 M |
$442.60 M |
$402.16 M |
$430.38 M |
$390.52 M |
$365.35 M |
$355.19 M |
$337.47 M |
$336.00 M |
| Gross Profit |
$676.25 M |
$571.25 M |
$568.04 M |
$460.30 M |
$524.72 M |
$469.11 M |
$431.04 M |
$408.33 M |
$381.70 M |
$398.47 M |
| Gross Profit Ratio |
0.54 |
0.55 |
0.56 |
0.53 |
0.55 |
0.55 |
0.54 |
0.53 |
0.53 |
0.54 |
| Research and Development
Expenses |
$52.60 M
|
$47.15 M
|
$43.57 M
|
$40.47 M
|
$45.46 M
|
$42.19 M
|
$32.31 M
|
$32.25 M
|
$27.44 M
|
$27.78 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$400.14 M
|
$355.62 M
|
$351.80 M
|
$338.40 M
|
$303.09 M
|
$293.94 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$504.71 M
|
$454.04 M
|
$414.75 M
|
$373.82 M
|
$400.14 M
|
$355.62 M
|
$351.80 M
|
$338.40 M
|
$303.09 M
|
$293.94 M
|
| Other Expenses |
$0.00 |
-$112.01 M |
-$1.13 M |
-$355,000.00 |
-$5.19 M |
$0.00 |
$0.00 |
-$2.94 M |
$0.00 |
$7.32 M |
| Operating Expenses |
$555.64 M |
$501.19 M |
$458.32 M |
$414.29 M |
$445.60 M |
$397.81 M |
$384.11 M |
$370.65 M |
$330.53 M |
$345.68 M |
| Cost And Expenses |
$1.12 B |
$975.42 M |
$900.92 M |
$816.45 M |
$875.98 M |
$788.33 M |
$749.46 M |
$725.84 M |
$667.99 M |
$681.68 M |
| Interest Income |
$0.00 |
$28.91 M |
$35.49 M |
$44.05 M |
$42.70 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$39.78 M |
$28.91 M |
$35.49 M |
$44.05 M |
$42.70 M |
$20.65 M |
$18.20 M |
$15.36 M |
$6.03 M |
$6.11 M |
| Depreciation &
Amortization |
$51.40 M
|
$49.76 M
|
$49.79 M
|
$52.24 M
|
$50.99 M
|
$61.80 M
|
$58.55 M
|
$55.31 M
|
$43.88 M
|
$45.73 M
|
| EBITDA |
$192.48 M
|
$7.80 M
|
$158.38 M
|
$113.58 M
|
$124.91 M
|
$133.11 M
|
$105.48 M
|
$90.04 M
|
$95.05 M
|
$98.52 M
|
| EBITDA Ratio |
0.15 |
-0.04 |
0.11 |
0.05 |
0.08 |
0.08 |
0.06 |
0.12 |
0.13 |
0.13 |
| Operating Income Ratio
|
0.11
|
0.07
|
0.04
|
-0.03
|
0
|
0.08
|
0.06
|
0.05
|
0.07
|
0.07
|
| Total Other
Income/Expenses Net |
-$49.96 M
|
-$140.92 M
|
-$36.61 M
|
-$44.41 M
|
-$47.89 M
|
-$20.65 M
|
-$18.20 M
|
-$18.30 M
|
-$6.03 M
|
-$6.11 M
|
| Income Before Tax |
$80.83 M |
-$70.86 M |
$73.11 M |
$1.60 M |
$31.23 M |
$50.65 M |
$28.73 M |
$19.38 M |
$45.14 M |
$46.68 M |
| Income Before Tax Ratio
|
0.06
|
-0.07
|
0.07
|
0
|
0.03
|
0.06
|
0.04
|
0.03
|
0.06
|
0.06
|
| Income Tax Expense |
$16.37 M |
$9.72 M |
$10.56 M |
-$7.91 M |
$2.61 M |
$9.80 M |
-$26.76 M |
$4.71 M |
$14.65 M |
$14.48 M |
| Net Income |
$64.46 M |
-$80.58 M |
$62.54 M |
$9.52 M |
$28.62 M |
$40.85 M |
$55.49 M |
$14.66 M |
$30.50 M |
$32.19 M |
| Net Income Ratio |
0.05 |
-0.08 |
0.06 |
0.01 |
0.03 |
0.05 |
0.07 |
0.02 |
0.04 |
0.04 |
| EPS |
2.1 |
-2.68 |
2.14 |
0.33 |
1.01 |
1.45 |
1.99 |
0.53 |
1.1 |
1.17 |
| EPS Diluted |
2.04 |
-2.68 |
1.94 |
0.32 |
0.97 |
1.41 |
1.97 |
0.52 |
1.09 |
1.16 |
| Weighted Average Shares
Out |
$30.67 M
|
$30.04 M
|
$29.16 M
|
$28.58 M
|
$28.33 M
|
$28.12 M
|
$27.94 M
|
$27.80 M
|
$27.65 M
|
$27.40 M
|
| Weighted Average Shares
Out Diluted |
$31.55 M
|
$30.04 M
|
$32.22 M
|
$29.46 M
|
$29.50 M
|
$28.89 M
|
$28.17 M
|
$27.96 M
|
$27.86 M
|
$27.77 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
